Keybank National Association OH reduced its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 2.1% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 336,551 shares of the pharmacy operator’s stock after selling 7,121 shares during the quarter. Keybank National Association OH’s holdings in Walgreens Boots Alliance were worth $26,355,000 at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of the company. Hudock Capital Group LLC grew its holdings in Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares during the period. Reilly Financial Advisors LLC boosted its holdings in shares of Walgreens Boots Alliance by 7.9% in the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after acquiring an additional 100 shares during the period. Orrstown Financial Services Inc. boosted its holdings in shares of Walgreens Boots Alliance by 14.1% in the second quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after acquiring an additional 213 shares during the period. Private Vista LLC raised its position in shares of Walgreens Boots Alliance by 6,403.7% in the second quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock worth $140,000 after buying an additional 574,218 shares in the last quarter. Finally, Hanson McClain Inc. raised its position in shares of Walgreens Boots Alliance by 4.6% in the second quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock worth $156,000 after buying an additional 87 shares in the last quarter. 63.79% of the stock is owned by hedge funds and other institutional investors.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now directly owns 16,415 shares in the company, valued at approximately $1,105,878.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John Anthony Lederer bought 20,000 shares of the company’s stock in a transaction on Thursday, October 26th. The stock was bought at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the purchase, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The disclosure for this purchase can be found here. 13.50% of the stock is currently owned by corporate insiders.
Walgreens Boots Alliance, Inc. (WBA) traded up $1.45 on Friday, hitting $70.99. 12,380,900 shares of the company’s stock traded hands, compared to its average volume of 5,343,083. Walgreens Boots Alliance, Inc. has a twelve month low of $63.82 and a twelve month high of $88.00. The company has a market cap of $70,204.04, a P/E ratio of 13.64, a PEG ratio of 1.24 and a beta of 1.20. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, beating the consensus estimate of $1.21 by $0.10. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The business’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.07 EPS. analysts forecast that Walgreens Boots Alliance, Inc. will post 5.55 earnings per share for the current year.
Walgreens Boots Alliance declared that its board has initiated a share buyback plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to purchase shares of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s board believes its shares are undervalued.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.25%. The ex-dividend date of this dividend is Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is 42.33%.
A number of equities research analysts have weighed in on WBA shares. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday. Citigroup Inc. decreased their price objective on Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a report on Thursday, November 2nd. UBS AG reiterated a “buy” rating and issued a $96.00 price objective (down previously from $97.00) on shares of Walgreens Boots Alliance in a report on Wednesday, August 23rd. Royal Bank of Canada began coverage on Walgreens Boots Alliance in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 target price on the stock. Finally, Jefferies Group LLC reissued a “buy” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Monday, October 2nd. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $87.63.
COPYRIGHT VIOLATION WARNING: “Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Holdings Trimmed by Keybank National Association OH” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/11/11/walgreens-boots-alliance-inc-wba-shares-sold-by-keybank-national-association-oh.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.